Brad M. Cerepak
Known title: Senior Vice President & CFOCIK: 0001333585
Associated companies
Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.
October 17, 2026
Dover Corp (DOV) Prepares for Q3 Earnings Amid Analyst Target Cuts. Dover is set to release its Q3 results next week, prompting several earnings previews. Analysts at Mizuho and RBC have kept their outperform ratings but lowered price targets to $245 and $216 respectively. Seeking Alpha notes that the stock has not fallen enough to justify an upgrade. A new CO₂ condensing unit from Hillphoenix may affect industrial demand, adding context to the upcoming report.
Transaction History
| VGNT | ▲ Buy | Grant | 5,168 | $0 | 4/22/2026 | View on chart |
| DOV | ▼ Sell | Open Market | 14,818 | $2.6M | 9/6/2024 | View on chart |
| DOV | ▲ Buy | Option Exercise | 40,000 | $2.5M | 8/30/2024 | View on chart |
| DOV | ▼ Sell | Other | 13,395 | $2.5M | 8/30/2024 | View on chart |
| DOV | ▼ Sell | Tax Withholding | 11,787 | $2.2M | 8/30/2024 | View on chart |
| DOV | ▼ Sell | Open Market | 4,341 | $801K | 7/31/2024 | View on chart |
| DOV | ▼ Sell | Tax Withholding | 485 | $85K | 3/15/2024 | View on chart |
| DOV | ▼ Sell | Tax Withholding | 371 | $65K | 3/15/2024 | View on chart |
| DOV | ▼ Sell | Tax Withholding | 388 | $68K | 3/15/2024 | View on chart |
| DOV | ▼ Sell | Open Market | 6,000 | $1.1M | 3/13/2024 | View on chart |
| DOV | ▼ Sell | Open Market | 18,410 | $3.0M | 2/23/2024 | View on chart |
| DOV | ▲ Buy | Grant | 2,654 | $0 | 2/8/2024 | View on chart |
| DOV | ▲ Buy | Grant | 5,305 | $0 | 2/8/2024 | View on chart |
| DOV | ▼ Sell | Tax Withholding | 1,578 | $253K | 2/8/2024 | View on chart |
| DOV | ▼ Sell | Open Market | 14,000 | $2.0M | 12/5/2023 | View on chart |
| DOV | ▼ Sell | Open Market | 4,631 | $658K | 9/7/2023 | View on chart |
| DOV | ▼ Sell | Open Market | 17,769 | $2.5M | 6/6/2023 | View on chart |
| DOV | ▼ Sell | Tax Withholding | 564 | $79K | 3/15/2023 | View on chart |
| DOV | ▼ Sell | Tax Withholding | 432 | $61K | 3/15/2023 | View on chart |
| DOV | ▼ Sell | Tax Withholding | 544 | $76K | 3/15/2023 | View on chart |
| DOV | ▼ Sell | Open Market | 26,886 | $3.8M | 3/13/2023 | View on chart |
| DOV | ▼ Sell | Open Market | 8,086 | $1.2M | 3/13/2023 | View on chart |
| DOV | ▼ Sell | Tax Withholding | 27,815 | $4.2M | 3/9/2023 | View on chart |
| DOV | ▲ Buy | Option Exercise | 91,981 | $4.4M | 3/9/2023 | View on chart |
| DOV | ▼ Sell | Other | 29,194 | $4.4M | 3/9/2023 | View on chart |
| DOV | ▼ Sell | Tax Withholding | 1,745 | $267K | 2/10/2023 | View on chart |
| DOV | ▲ Buy | Grant | 2,773 | $0 | 2/10/2023 | View on chart |
| DOV | ▲ Buy | Grant | 4,765 | $0 | 2/10/2023 | View on chart |
| DOV | ▼ Sell | Tax Withholding | 564 | $86K | 3/15/2022 | View on chart |
| DOV | ▼ Sell | Tax Withholding | 714 | $108K | 3/15/2022 | View on chart |
| DOV | ▼ Sell | Tax Withholding | 543 | $82K | 3/15/2022 | View on chart |
| DOV | ▼ Sell | Tax Withholding | 5,811 | $931K | 2/11/2022 | View on chart |
| DOV | ▲ Buy | Grant | 13,158 | $0 | 2/11/2022 | View on chart |
| DOV | ▲ Buy | Grant | 2,653 | $0 | 2/11/2022 | View on chart |
| DOV | ▼ Sell | Open Market | 2,216 | $368K | 12/1/2021 | View on chart |
| DOV | ▼ Sell | Open Market | 17,817 | $3.0M | 12/1/2021 | View on chart |
| DOV | ▼ Sell | Tax Withholding | 18,655 | $3.3M | 11/23/2021 | View on chart |
| DOV | ▼ Sell | Other | 23,899 | $4.2M | 11/23/2021 | View on chart |
| DOV | ▲ Buy | Option Exercise | 60,371 | $4.2M | 11/23/2021 | View on chart |
AI Market Commentary
AI-generatedAll commentary →Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.
September 28, 2026
Versigent Releases Q2 2026 Earnings Call Transcript
Versigent PLC has published the transcript of its Q2 2026 earnings call. The release gives investors access to management’s discussion of the quarter’s performance and outlook. The transcript is available through Benzinga and provides context for the company’s recent financial results.
Versigent Releases Q2 2026 Earnings Call Transcript. Versigent PLC has published the transcript of its Q2 2026 earnings call. The release gives investors access to management’s discussion of the quarter’s performance and outlook. The transcript is available through Benzinga and provides context for the company’s recent financial results.